🇺🇸 FDA
Pipeline program

Azilsartan (Zhaoke)

ZK-HK-AZI-201705

Phase 1 small_molecule completed

Quick answer

Azilsartan (Zhaoke) for Bioequivalence of Two Azilsartan Formulations is a Phase 1 program (small_molecule) at Lee's Pharmaceutical Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Lee's Pharmaceutical Limited
Indication
Bioequivalence of Two Azilsartan Formulations
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials